Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
Sponsored by AstraZeneca
About this trial
Last updated 12 years ago
Study ID
NIS-PLA-XXX-2011/1
Status
Completed
Type
Observational
Placebo
No
Accepting
21+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 12 years ago
What is this trial about?
RATIONAL is a multinational, multicentre, observational, cross sectional study of adult
patients in treatment with NSAID therapy for OA, RA or AS during for at least 2 weeks
before study visit (at least one dose).
What are the participation requirements?
Inclusion Criteria
- Provision of subject informed consent.
- Female and/or male, aged > 21 years.
- Patients diagnosis with RA (ACR 1987 or ACR/EULAR 2010 criteria), OA (ACR 1986, 1990 and 1991 criteria) or AS (New York 1984 criteria or ESSG 2002 criteria) (documented in the medical record).
- Patients receiving at least one dose of NSAIDs.
Exclusion Criteria
- Participation in any interventional study involving investigational drugs.
- Patient refuses to fill in the study questionnaires.
- Pregnant or breastfeeding women.
- Patients with active neoplastic disease in the last 5 years, except basal-cell carcinoma.